2 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
Follow Melasma: new trials by email Literature Review of Melasma trials Research Report on Melasma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma 22% TCA peel, CO2 laser, Qs-NdYag laser - Melasma | Phase 1 | Withdrawn | SUZAN OBAGI | 2020-12-01 | 2020-03-25 | |
| Spironolactone for the Treatment of Melasma Spironolactone 50Mg Tablet, Spironolactone 100Mg Tablet, Spironolactone 200Mg - Melasma | Phase 1 | Withdrawn | Medical University of South Carolina | 2020-03-05 | 2024-09-04 |
Melanosis (2)
Hyperpigmentation (2) · Pigmentation Disorders (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
Canrenoic Acid (1) · Lasers, Gas (1) · Spironolactone (1) · Tablets (1)
Medical University of South Carolina (1) · SUZAN OBAGI (1)
United States (1)
Dirk Elston, MD (1) · Suzan Obagi, MD (1)